Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

“My son’s lips, at this point, started to turn blue. He also had a febrile seizure, which is why his body was stiff and ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

It is the first approval for Beyfortus (nirsevimab) by any regulatory authority. AZ's Synagis (palivizumab) is currently the only approved drug in Europe to provide passive prophylaxis against RSV ...

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate "safe and helpful answers" to questions posed by healthcare professionals ...

L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.

A vaccine designed to help protect babies from the respiratory syncytial virus (RSV) is now free during pregnancy. RSV is the ...

The one-off therapy, nirsevimab, is designed to protect again illness from respiratory syncytial virus (RSV) which can be deadly for infants. RSV is one of a number of viruses that surge in winter ...

One Zelienople child survived a serious health scare after coming down with respiratory syncytial virus in late January. The ...

The Illinois Department of Public Health (IDPH) announced that in line with the national trend, the state’s overall respiratory illness level has ticked up from Moderate to High, driven by ...